Researchers found “no significant discrepancy in safety events” between trastuzumab biosimilars and the originator product.

Democrats and Republicans in statehouses around the country have been working together to tackle the nation’s medical debt crisis.

Patients with EGFR-mutant, oligometastatic NSCLC who received radiotherapy plus icotinib had longer overall and progression-free survival than those who received icotinib alone.

More than half of US physician peer reviewers for the most influential medical journals receive industry payments, according to research.

Hospitals have been bracing for a nationwide shortage of IV fluids after Hurricane Helene knocked out a North Carolina production plant, but a plant in Daytona Beach, Florida, was spared by Hurricane ...

Some physicians have urged their colleagues and medical societies to move professional conferences out of states that ...

The FDA has approved Itovebi in combination with palbociclib and fulvestrant to treat certain patients with PIK3CA-mutant breast cancer.

The United States launched the most new cancer drugs during the study period (n=345). Other countries with a high number of launches were Japan (n=224), Canada (n=221), Australia (n=204), the United ...

A machine learning survival model that selects patients for serious illness conversations can increase the rate of advance ...

Hypofractionated PMRT is safe and effective in breast cancer patients undergoing reconstruction and should be moved into ...

Half of patients surveyed said they would be less likely to open a patient portal account if they thought their parents would be able to access their medical information.

Artificial intelligence may be able to estimate the risk of future breast cancer and lead to earlier diagnosis, a new study suggests.